Health-Care Transactions Update: Will 2018 Surpass 2017?

 

By Gary W. Herschman, Kevin J. Ryan, Victoria Poindexter, Robert April, Michael J. Tierney, and Michael Mahoney  | January 25, 2018

 

Gary W. Herschman is a member of Epstein Becker & Green in its Newark, N.J., office. He can be reached at gherschman@ebglaw.com. Kevin J. Ryan is a member of Epstein Becker & Green PC in its Chicago office. He can be reached at kryan@ebglaw.com. Victoria Poindexter is a principal with Hammond Hanlon Camp LLC, an independent investment banking and strategic advisory firm, in Chicago. She can be reached at vpoindexter@h2c.com. Michael Tierney is a vice president in the Chicago office of Hammond Hanlon Camp LLC. He can be reached at mtierney@h2c.com. Robert Aprill is an analyst with Provident Healthcare Partners LLC, a leading middle market investment bank, in Boston. He can be reached at raprill@providenthp.com. Michael Mahoney is an analyst with Provident Healthcare Partners in Los Angeles. He can be reached at mmahoney@providenthp.com.


Health-care industry deal activity has been going strong ever since the Affordable Care Act took effect in 2010. There was some trepidation it might slow down when the Trump administration took over, but the 2017 transactions year-to-date list shows the failed push to repeal the health-care law seems to have calmed any concerns.
 

Rumors that Congress might take up the repeal issue again in 2018 haven't revived those concerns, as witnessed by the boom in big deals announced at the end of 2017 that will close in the coming year. If anything, the deals have gotten bigger—creating huge health-care entities that incorporate a variety of different services.


Bloomberg Law's transactions editorial advisory board takes a look at the activity that ended the year and projects there will be a vigorous deal climate in 2018.

 

. . .

 

Source: Bloomberg BNA's Health Law Reporter

ABOUT HAMMOND HANLON CAMP LLC

Hammond Hanlon Camp LLC (“H2C”) is an independent strategic advisory and investment banking firm committed to providing superior advice as a trusted advisor to healthcare organizations throughout the United States. H2C’s professionals have a long track record of success in healthcare mergers & acquisitions, capital markets, real estate and restructuring transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value. Hammond Hanlon Camp LLC offers securities through its wholly-owned subsidiary H2C Securities Inc., member FINRA/SIPC. For more information, go to h2c.com

 

MEDIA CONTACT

Dara Litwin
Hammond Hanlon Camp LLC
212.257.4527
dlitwin@h2c.com

NEW YORK

623 Fifth Avenue
29th Floor
New York, NY 10022
212.257.4500

 

ATLANTA

3333 Piedmont Road
Suite 700
Atlanta, GA 30305
404.937.1350

 

CHICAGO

311 South Wacker Drive
Suite 5425
Chicago, IL 60606
312.508.4200

 

H2C Thought Leaders Offer Bloomberg BNA Insight on Projected Transaction Activity in 2018
posted on January 26, 2018

 

Victoria Poindexter, Principal at Hammond Hanlon Camp LLC ("H2C"), and Mike Tierney, Vice President at H2C, offer their perspectives on projected M&A transaction activity in 2018 given our current healthcare climate. View the complete article below.

SAN DIEGO

4655 Executive Drive Suite 280
San Diego, CA 92121
858.242.4800